Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
Regionshospitalet Silkeborg
Rigshospitalet, Denmark
N.N. Petrov National Medical Research Center of Oncology
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Duke University
Gustave Roussy, Cancer Campus, Grand Paris